OPKO Health, Inc.
OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137
(305) 575 4100Website: https://www.opko.com/Careers: https://www.opko.com/careers
Latest News
- FDA Approves Rayaldee (calcifediol) to Treat Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease - June 21, 2016
- FDA Accepts Resubmission of New Drug Application for Rayaldee - April 27, 2016
- OPKO Receives Complete Response Letter from FDA for Rayaldee New Drug Application - March 30, 2016
- FDA Accepts OPKO's New Drug Application for Rayaldee - July 28, 2015
- OPKO Announces Submission of Rayaldee NDA - June 2, 2015
Drugs Associated with OPKO Health, Inc.
OPKO Health, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Rayaldee
Generic name: calcifediol Drug class: vitamins |
7 reviews | 7.9 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||